2014-2026 Global Metabolism Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

SKU ID :Maia-15086015 | Published Date: 14-Jan-2020 | No. of pages: 111
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Metabolism Drugs Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Metabolism Drugs Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Metabolism Drugs Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Metabolism Drugs Market-Segmentation by Type 5.1 Amino Acid Metabolism Drug 5.2 Lipid Metabolism Disease Drug 5.3 Glycogen Metabolism Disease Drug 6 Global Metabolism Drugs Market-Segmentation by Application 6.1 Retail Pharmacy 6.2 Hospital 7 Global Metabolism Drugs Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 LG Life Science 8.1.1 LG Life Science Profile 8.1.2 LG Life Science Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 LG Life Science Product/Solution Launches and Enhancements Analysis 8.1.4 LG Life Science Business Overview/Recent Development/Acquisitions 8.2 Kythera 8.2.1 Kythera Profile 8.2.2 Kythera Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Kythera Product/Solution Launches and Enhancements Analysis 8.2.4 Kythera Business Overview/Recent Development/Acquisitions 8.3 Astra Zeneca 8.3.1 Astra Zeneca Profile 8.3.2 Astra Zeneca Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Astra Zeneca Product/Solution Launches and Enhancements Analysis 8.3.4 Astra Zeneca Business Overview/Recent Development/Acquisitions 8.4 Takeda Pharmaceutical 8.4.1 Takeda Pharmaceutical Profile 8.4.2 Takeda Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Takeda Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.4.4 Takeda Pharmaceutical Business Overview/Recent Development/Acquisitions 8.5 KOWA 8.5.1 KOWA Profile 8.5.2 KOWA Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 KOWA Product/Solution Launches and Enhancements Analysis 8.5.4 KOWA Business Overview/Recent Development/Acquisitions 8.6 Merck 8.6.1 Merck Profile 8.6.2 Merck Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Merck Product/Solution Launches and Enhancements Analysis 8.6.4 Merck Business Overview/Recent Development/Acquisitions 8.7 Novartis 8.7.1 Novartis Profile 8.7.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Novartis Product/Solution Launches and Enhancements Analysis 8.7.4 Novartis Business Overview/Recent Development/Acquisitions 8.8 Metsubishi Tanabe Pharma 8.8.1 Metsubishi Tanabe Pharma Profile 8.8.2 Metsubishi Tanabe Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Metsubishi Tanabe Pharma Product/Solution Launches and Enhancements Analysis 8.8.4 Metsubishi Tanabe Pharma Business Overview/Recent Development/Acquisitions 8.9 Beohrigher Ingelheim 8.9.1 Beohrigher Ingelheim Profile 8.9.2 Beohrigher Ingelheim Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Beohrigher Ingelheim Product/Solution Launches and Enhancements Analysis 8.9.4 Beohrigher Ingelheim Business Overview/Recent Development/Acquisitions 8.10 Fuji yakuhin 8.10.1 Fuji yakuhin Profile 8.10.2 Fuji yakuhin Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Fuji yakuhin Product/Solution Launches and Enhancements Analysis 8.10.4 Fuji yakuhin Business Overview/Recent Development/Acquisitions 9 Global Metabolism Drugs Market-Segmentation by Geography 10 North America 10.1 North America Metabolism Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Metabolism Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Metabolism Drugs Production Analysis from 2014-2019E 10.4 North America Metabolism Drugs Consumption Analysis from 2014-2019E 10.5 North America Metabolism Drugs Import and Export from 2014-2019E 10.6 North America Metabolism Drugs Value, Production and Market Share by Type (2014-2019E) 10.7 North America Metabolism Drugs Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Metabolism Drugs by Country (United States, Canada) 10.8.1 North America Metabolism Drugs Sales by Country (2014-2019E) 10.8.2 North America Metabolism Drugs Consumption Value by Country (2014-2019E) 10.9 North America Metabolism Drugs Market PEST Analysis 11 Europe 11.1 Europe Metabolism Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Metabolism Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Metabolism Drugs Production Analysis from 2014-2019E 11.4 Europe Metabolism Drugs Consumption Analysis from 2014-2019E 11.5 Europe Metabolism Drugs Import and Export from 2014-2019E 11.6 Europe Metabolism Drugs Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Metabolism Drugs Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Metabolism Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Metabolism Drugs Sales by Country (2014-2019E) 11.8.2 Europe Metabolism Drugs Consumption Value by Country (2014-2019E) 11.9 Europe Metabolism Drugs Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Metabolism Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Metabolism Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Metabolism Drugs Production Analysis from 2014-2019E 12.4 Asia-Pacific Metabolism Drugs Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Metabolism Drugs Import and Export from 2014-2019E 12.6 Asia-Pacific Metabolism Drugs Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Metabolism Drugs Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Metabolism Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Metabolism Drugs Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Metabolism Drugs Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Metabolism Drugs Market PEST Analysis 13 Latin America 13.1 Latin America Metabolism Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Metabolism Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Metabolism Drugs Production Analysis from 2014-2019E 13.4 Latin America Metabolism Drugs Consumption Analysis from 2014-2019E 13.5 Latin America Metabolism Drugs Import and Export from 2014-2019E 13.6 Latin America Metabolism Drugs Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Metabolism Drugs Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Metabolism Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Metabolism Drugs Sales by Country (2014-2019E) 13.8.2 Latin America Metabolism Drugs Consumption Value by Country (2014-2019E) 13.9 Latin America Metabolism Drugs Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Metabolism Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Metabolism Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Metabolism Drugs Production Analysis from 2014-2019E 14.4 Middle East & Africa Metabolism Drugs Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Metabolism Drugs Import and Export from 2014-2019E 14.6 Middle East & Africa Metabolism Drugs Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Metabolism Drugs Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Metabolism Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Metabolism Drugs Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Metabolism Drugs Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Metabolism Drugs Market PEST Analysis 15 Future Forecast of the Global Metabolism Drugs Market from 2018-2026 15.1 Future Forecast of the Global Metabolism Drugs Market from 2019-2026 Segment by Region 15.2 Global Metabolism Drugs Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Metabolism Drugs Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source
List of Tables and Figures Global Metabolism Drugs Market Value ($) and Growth Rate of Metabolism Drugs from 2014-2026 Global Metabolism Drugs Production and Growth Rate Segment by Product Type from 2014-2026F Global Metabolism Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Figure Metabolism Drugs Picture Table Product Specifications of Metabolism Drugs Table Driving Factors for this Market Table Industry News of Metabolism Drugs Market Figure Value Chain Status of Metabolism Drugs Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Metabolism Drugs Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Metabolism Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Amino Acid Metabolism Drug of Metabolism Drugs Figure Lipid Metabolism Disease Drug of Metabolism Drugs Figure Glycogen Metabolism Disease Drug of Metabolism Drugs Table Global Metabolism Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Metabolism Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Retail Pharmacy of Metabolism Drugs Figure Hospital of Metabolism Drugs Table Global Metabolism Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Metabolism Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Metabolism Drugs Figure Online Channel of Metabolism Drugs Table LG Life Science Profile (Company Name, Plants Distribution, Sales Region) Figure LG Life Science Sales and Growth Rate from 2014-2019E Figure LG Life Science Revenue ($) and Global Market Share from 2014-2019E Table LG Life Science Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Kythera Profile (Company Name, Plants Distribution, Sales Region) Figure Kythera Sales and Growth Rate from 2014-2019E Figure Kythera Revenue ($) and Global Market Share from 2014-2019E Table Kythera Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Astra Zeneca Profile (Company Name, Plants Distribution, Sales Region) Figure Astra Zeneca Sales and Growth Rate from 2014-2019E Figure Astra Zeneca Revenue ($) and Global Market Share from 2014-2019E Table Astra Zeneca Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Takeda Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure Takeda Pharmaceutical Sales and Growth Rate from 2014-2019E Figure Takeda Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table Takeda Pharmaceutical Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table KOWA Profile (Company Name, Plants Distribution, Sales Region) Figure KOWA Sales and Growth Rate from 2014-2019E Figure KOWA Revenue ($) and Global Market Share from 2014-2019E Table KOWA Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck Profile (Company Name, Plants Distribution, Sales Region) Figure Merck Sales and Growth Rate from 2014-2019E Figure Merck Revenue ($) and Global Market Share from 2014-2019E Table Merck Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Metsubishi Tanabe Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure Metsubishi Tanabe Pharma Sales and Growth Rate from 2014-2019E Figure Metsubishi Tanabe Pharma Revenue ($) and Global Market Share from 2014-2019E Table Metsubishi Tanabe Pharma Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Beohrigher Ingelheim Profile (Company Name, Plants Distribution, Sales Region) Figure Beohrigher Ingelheim Sales and Growth Rate from 2014-2019E Figure Beohrigher Ingelheim Revenue ($) and Global Market Share from 2014-2019E Table Beohrigher Ingelheim Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Fuji yakuhin Profile (Company Name, Plants Distribution, Sales Region) Figure Fuji yakuhin Sales and Growth Rate from 2014-2019E Figure Fuji yakuhin Revenue ($) and Global Market Share from 2014-2019E Table Fuji yakuhin Metabolism Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Metabolism Drugs Production Value ($) by Region from 2014-2019E Table Global Metabolism Drugs Production Value Share by Region from 2014-2019E Table Global Metabolism Drugs Production by Region from 2014-2019E Table Global Metabolism Drugs Consumption Value ($) by Region from 2014-2019E Table Global Metabolism Drugs Consumption by Region from 2014-2019E Table North America Metabolism Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Metabolism Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Metabolism Drugs Import and Export from 2014-2019E Table North America Metabolism Drugs Value ($) by Type (2014-2019E) Table North America Metabolism Drugs Production by Type (2014-2019E) Table North America Metabolism Drugs Consumption by Application (2014-2019E) Table North America Metabolism Drugs Consumption by Country (2014-2019E) Table North America Metabolism Drugs Consumption Value ($) by Country (2014-2019E) Figure North America Metabolism Drugs Market PEST Analysis Table Europe Metabolism Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Metabolism Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Metabolism Drugs Import and Export from 2014-2019E Table Europe Metabolism Drugs Value ($) by Type (2014-2019E) Table Europe Metabolism Drugs Production by Type (2014-2019E) Table Europe Metabolism Drugs Consumption by Application (2014-2019E) Table Europe Metabolism Drugs Consumption by Country (2014-2019E) Table Europe Metabolism Drugs Consumption Value ($) by Country (2014-2019E) Figure Europe Metabolism Drugs Market PEST Analysis Table Asia-Pacific Metabolism Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Metabolism Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Metabolism Drugs Import and Export from 2014-2019E Table Asia-Pacific Metabolism Drugs Value ($) by Type (2014-2019E) Table Asia-Pacific Metabolism Drugs Production by Type (2014-2019E) Table Asia-Pacific Metabolism Drugs Consumption by Application (2014-2019E) Table Asia-Pacific Metabolism Drugs Consumption by Country (2014-2019E) Table Asia-Pacific Metabolism Drugs Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Metabolism Drugs Market PEST Analysis Table Latin America Metabolism Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Metabolism Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Metabolism Drugs Import and Export from 2014-2019E Table Latin America Metabolism Drugs Value ($) by Type (2014-2019E) Table Latin America Metabolism Drugs Production by Type (2014-2019E) Table Latin America Metabolism Drugs Consumption by Application (2014-2019E) Table Latin America Metabolism Drugs Consumption by Country (2014-2019E) Table Latin America Metabolism Drugs Consumption Value ($) by Country (2014-2019E) Figure Latin America Metabolism Drugs Market PEST Analysis Table Middle East & Africa Metabolism Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Metabolism Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Metabolism Drugs Import and Export from 2014-2019E Table Middle East & Africa Metabolism Drugs Value ($) by Type (2014-2019E) Table Middle East & Africa Metabolism Drugs Production by Type (2014-2019E) Table Middle East & Africa Metabolism Drugs Consumption by Application (2014-2019E) Table Middle East & Africa Metabolism Drugs Consumption by Country (2014-2019E) Table Middle East & Africa Metabolism Drugs Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Metabolism Drugs Market PEST Analysis Table Global Metabolism Drugs Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Metabolism Drugs Production and Growth Rate Forecast by Region (2019-2026) Table Global Metabolism Drugs Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Metabolism Drugs Production and Growth Rate Forecast by Type (2019-2026) Table Global Metabolism Drugs Consumption and Growth Rate Forecast by Application (2019-2026)
  • PRICE
  • $3460
    $5000
    Buy Now

Our Clients